Covid: How will I get a coronavirus vaccine?

.css-94m6rd-HeadingWrapper{border-bottom:solid 1px #BABABA;padding-bottom:1.5rem;}.css-94m6rd-HeadingWrapper > *:not([hidden]):not(style) ~ *:not([hidden]):not(style){margin-top:1rem;} .css-1c1994u-StyledHeading{font-family:ReithSerif,Helvetica,Arial,freesans,sans-serif;font-weight:500;font-size:2rem;line-height:2.25rem;color:#3F3F42;}@media (min-width:37.5rem){.css-1c1994u-StyledHeading{font-size:2.75rem;line-height:3rem;}}.css-1c1994u-StyledHeading:focus{outline-style:none;}.css-1c1994u-StyledHeading:focus-visible{outline-style:auto;}.css-15hnagr-Contributor{font-family:ReithSans,Helvetica,Arial,freesans,sans-serif;font-weight:400;font-size:0.8125rem;line-height:1rem;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;color:#696969;}.css-15hnagr-Contributor strong{font-family:ReithSerif,Helvetica,Arial,freesans,sans-serif;font-weight:500;color:#3F3F42;} By Philippa RoxbyHealth reporter .css-11c8au8-MetadataStrip{font-family:ReithSans,Helvetica,Arial,freesans,sans-serif;font-weight:400;font-size:0.8125rem;line-height:1rem;margin-top:-0.25rem;color:#696969;} .css-8d0yke-MetadataStripItem{display:inline-block;white-space:nowrap;margin-top:0.25rem;max-width:calc(100% – 1em);}.css-8d0yke-MetadataStripItem::after{content:”;display:inline-block;height:1.25em;border-left:#BABABA 1px solid;margin:0 0.5em;vertical-align:-0.25em;}.css-8d0yke-MetadataStripItem:last-child{max-width:100%;}.css-8d0yke-MetadataStripItem:last-child::after{content:none;} .css-vk3nhx-ComponentWrapper{margin:1.5rem 0;} .css-1759m9z-StyledFigure{font-family:ReithSans,Helvetica,Arial,freesans,sans-serif;font-weight:400;font-size:0.875rem;line-height:1.125rem;} .css-kwaqyc-StyledFigureContainer{position:relative;} .css-1xtcmof-Placeholder{position:relative;display:block;padding-bottom:56.25%;background-color:#EEEEEE;}.css-1xtcmof-Placeholder img{overflow:hidden;position:absolute;top:0;right:0;bottom:0;left:0;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;width:100%;height:100%;object-fit:cover;}.css-evoj7m-Image{display:block;width:100%;height:auto;}.css-1ecljvk-StyledFigureCopyright{position:absolute;bottom:0;right:0;background:#3F3F42;color:#EEEEEE;padding:0.25rem 0.5rem;text-transform:uppercase;}image copyrightScience Photo Library .css-uf6wea-RichTextComponentWrapper{margin:1rem 0;max-width:36.25rem;} .css-83cqas-RichTextContainer{color:#3F3F42;}.css-83cqas-RichTextContainer > *:not([hidden]):not(style) ~ *:not([hidden]):not(style){margin-top:1rem;} .css-14iz86j-BoldText{font-weight:bold;}Four Covid vaccines have shown very promising results in final-stage trials, so …

Read More »

JD Sports in talks with Debenhams about rescue takeover

JD Sports is in talks with Debenhams about a rescue takeover that could secure thousands of jobs.  The FTSE100 trainer and sports fashion seller is interested in buying the whole chain and opened talks with its administrators yesterday.  Debenhams, which has 124 stores and 12,000 staff, went into administration in …

Read More »

Daily Mail and Mail on Sunday owner increases dividend

The owner of the Daily Mail and Mail on Sunday increased the dividend for investors but reported a fall in profits.  In a boost to shareholders, Daily Mail & General Trust said its payout would rise by 1 per cent to 24.1p for the year to September 30.  Increase: Daily Mail …

Read More »

AA banking on £218m private equity rescue

The AA looks set to end its disastrous run on the stock market after bosses said they were prepared to accept a £218m takeover offer from private equity.  Under the deal being discussed, Towerbrook Capital and Warburg Pincus would pay 35p per share to buy the debt-riddled roadside recovery firm.  …

Read More »

Astrazeneca vaccine gives stocks shot in the arm

Travel, oil and leisure stocks stormed higher after trials showed the coronavirus vaccine developed by Astrazeneca and Oxford University could be 90 per cent effective.  As Bank of England governor Andrew Bailey hailed ‘excellent news’, shares in holiday company Tui jumped 8.1 per cent while EasyJet was up 6.3 per …

Read More »

City regulators told to halt Cerberus’s Co-op bid

City regulators are under mounting pressure to block the takeover of Co-op Bank by ‘aggressive’ private equity firm Cerberus.  The Financial Conduct Authority (FCA) and the Bank of England’s Prudential Regulation Authority (PRA) must step in to prevent the infamous US firm ‘wrecking more lives’, campaigners have warned.  Both the …

Read More »

ALEX BRUMMER: Big pharma’s heroism deserves recognition

The Oxford AstraZeneca Covid-19 vaccine has finally reached the finish line. The cheers were more muted than they were for Pfizer and Moderna, which achieved a higher percentage result.  Much of the share price reward has already been taken, with AZ’s market value close to the top of the FTSE100 …

Read More »

MARKET REPORT: Sthree cheers investors

In a time of furlough, mass job cuts in many industries and the prospect of a double-dip recession, a lot has been stacked against recruitment firms.  Small-cap group Sthree is among the many companies that have been braced for the worst.  But Sthree gave the market a pleasant surprise by …

Read More »
RSS
Follow by Email
Pinterest